Self-Immunization with Live Attenuated Influenza Vaccine in a Mass Vaccination Clinic

By  

Disaster Medicine and Public Health Preparedness, Vol. 7, Iss. 2, 2013-04 ,pp. : 215-217

Cambridge University Press

Access to resources Recommend Favorite

The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink study

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 27, Iss. 1, 2018-01 ,pp. : 59-68

John Wiley & Sons Inc

Access to resources Recommend Favorite

The problem of multiplicity in malaria vaccine development

By Mons B.  

Annals of Tropical Medicine and Parasitology, Vol. 91, Iss. 2, 1997-03 ,pp. : 55-58

Maney Publishing

Access to resources Recommend Favorite

Preclinical Development of a Vaccine ‘Against Smoking’

By  

Oncology Research and Treatment, Vol. 25, Iss. 5, 2002-11 ,pp. : 406-411

Karger

Access to resources Recommend Favorite

Immunogenicity and Reactogenicity of a Single Dose of Live Attenuated Varicella Vaccine and a Booster Dose of Measles-Mumps-Rubella Vaccine Given Concomitantly at 12 years of Age

By Parment Per Arne   Svahn Anita   Rudén Ulla   Bråkenhielm Görel   Storsaeter Jann   Åkesson Lena   Linde Annika  

Scandinavian Journal of Infectious Diseases, Vol. 35, Iss. 10, 2003-10 ,pp. : 736-742

Informa Healthcare

Access to resources Recommend Favorite